BEPIROVIRSEN (BPV) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION CONTROLLED BY NUCLEOS(T)IDE ANALOGUE THERAPY: HBV DNA AND HBsAg LOSS 6 MONTHS AFTER END OF BPV TREATMENT (B-CLEAR STUDY)

被引：0
|
作者：
Yuen, Man-Fung
Lim, Seng Gee
Plesniak, Robert
Tsuji, Keiji
Diaconescu, Gheorghe
Gadano, Adrian C.
Asselah, Tarik
Yim, Hyung-Joon
Heo, Jeong
Rizzardini, Giuliano
Janssen, Harry L.
Popescu, Corneliu Petru
Stefanova-Petrova, Diana
Wong, Alexander
Idriz, Nevin
Pojoga, Cristina
Tanaka, Yasuhito
Janczewska, Ewa
Cremer, Jennifer
Elston, Robert
Lukic, Tamara
Maynard, Lauren
Kendrick, Stuart
Bharania, Punam
Campbell, Fiona
Paff, Melanie
Theodore, Dickens
机构：
来源：
HEPATOLOGY | 2023年 / 77卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
5015
引用
收藏
页码：E129 / E130
页数：2
相关论文
共 50 条
  • [41] Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection
    Janssen, Harry L. A.
    Hou, Jinlin
    Asselah, Tarik
    Chan, Henry L. Y.
    Zoulim, Fabien
    Tanaka, Yasuhito
    Janczewska, Ewa
    Nahass, Ronald G.
    Bourgeois, Stefan
    Buti, Maria
    Lampertico, Pietro
    Lenz, Oliver
    Verbinnen, Thierry
    Vandenbossche, Joris
    Talloen, Willem
    Kalmeijer, Ronald
    Beumont, Maria
    Biermer, Michael
    Shukla, Umesh
    GUT, 2023, 72 (07) : 1385 - 1398
  • [42] Hepatic Decompensation in Patients With HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) Triple Infection Versus HIV/HCV Coinfection and the Effect of Anti-HBV Nucleos(t)ide Therapy
    Lo Re, Vincent, III
    Wang, Li
    Devine, Scott
    Baser, Onur
    Olufade, Temitope
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (07) : 1027 - 1031
  • [43] Keystone to Secure Safety After Stopping Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B Patients Reply
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Nguyen, Mindie H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1891 - 1892
  • [44] Trend patterns of HBsAg kinetics in chronic hepatitis B patients during nucleos(t)ide analogue therapy based on ARMA models
    Yu, Hsien-Chung
    Huo, Wen-Wei
    Lin, Kung-Hung
    Sun, Wei-Chih
    Lee, Ching-Nun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (06) : 458 - 469
  • [45] RETRACTED: Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment (Retracted Article)
    Sun, Haixia
    Liu, Yinhui
    Zhang, Yufeng
    Jie, Yusheng
    Wu, Yuankai
    Li, Zhanyi
    Wei, Xuxia
    Li, Xiangyong
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [46] The Baseline and On treatment Predictive Factors of Hepatitis B Relapse after Nucleos(t)ide Analogue Discontinuation in Chronic Hepatitis B: A Prospective study
    Kaewdech, Apichat
    Sripongpun, Pimsiri
    Jundee, Sawangpong
    Chamroonkul, Naichaya
    Piratvisuth, Teerha
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 236 - 236
  • [47] Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy
    Carey, Ivana
    Gersch, Jeffrey
    Wang, Bo
    Moigboi, Christiana
    Kuhns, Mary
    Cloherty, Gavin
    Dusheiko, Geoffrey
    Agarwal, Kosh
    HEPATOLOGY, 2020, 72 (01) : 42 - 57
  • [48] Hepatitis B virus kinetics after nucleos(t)ide-analoguewithdrawal in chronic HBeAg(-) hepatitis correlates with HBV-specific CD8+response and HBsAg level
    Pena Asensio, Julia
    Sanz-de Villalobos, Eduardo
    Miquel, Joaquin
    Gonzalez Praetorius, Alejandro
    Ramon Larrubia, Juan
    JOURNAL OF HEPATOLOGY, 2020, 73 : S573 - S574
  • [49] IMPROVED HBsAg LOSS RATE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PROLONGED PEGINTERFERON α-2a COMBINED WITH NUCLEOS(T)IDE ANALOGUE
    Wang, S. Q.
    Xu, K. J.
    Wu, J. Z.
    Luongo, T. T.
    Yang, R. G.
    Geng, X. X.
    Huang, R. G.
    Lin, J. M.
    Yang, X. X.
    Jiang, N.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S317 - S317
  • [50] Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B
    Rinker, Franziska
    Zimmer, Christine L.
    zu Siederdissen, Christoph Hoener
    Manns, Michael P.
    Kraft, Anke R. M.
    Wedemeyer, Heiner
    Bjoerkstroem, Niklas K.
    Cornberg, Markus
    JOURNAL OF HEPATOLOGY, 2018, 69 (03) : 584 - 593
12345